Wolverine Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.16M Buy
42,447
+4,036
+11% +$102K ﹤0.01% 2745
2025
Q2
$933K Buy
38,411
+15,032
+64% +$329K ﹤0.01% 2375
2025
Q1
$504K Buy
23,379
+9,745
+71% +$245K ﹤0.01% 2959
2024
Q4
$323K Sell
13,634
-34,872
-72% -$858K ﹤0.01% 3942
2024
Q3
$1.24M Sell
48,506
-53,639
-53% -$1.37M ﹤0.01% 2140
2024
Q2
$2.4M Buy
102,145
+1,416
+1% +$35.7K ﹤0.01% 1472
2024
Q1
$2.9M Buy
100,729
+60,771
+152% +$1.83M ﹤0.01% 1358
2023
Q4
$1.31M Buy
39,958
+4,724
+13% +$128K ﹤0.01% 2037
2023
Q3
$982K Buy
35,234
+12,182
+53% +$398K ﹤0.01% 2124
2023
Q2
$777K Buy
23,052
+14,896
+183% +$468K ﹤0.01% 2226
2023
Q1
$234K Sell
8,156
-9,074
-53% -$281K ﹤0.01% 3273
2022
Q4
$486K Sell
17,230
-415
-2% -$13.2K ﹤0.01% 2352
2022
Q3
$580K Buy
17,645
+8,157
+86% +$299K ﹤0.01% 2488
2022
Q2
$305K Buy
+9,488
New +$332K ﹤0.01% 3063
2022
Q1
Sell
-6,586
Closed -$410K 5354
2021
Q4
$410K Buy
6,586
+867
+15% +$59.9K ﹤0.01% 3716
2021
Q3
$422K Buy
+5,719
New +$480K ﹤0.01% 4180
2021
Q2
Sell
-5,343
Closed -$451K 5883
2021
Q1
$451K Buy
+5,343
New +$530K ﹤0.01% 3855
2020
Q4
Sell
-19,526
Closed -$1.25M 4766
2020
Q3
$1.25M Buy
19,526
+12,379
+173% +$725K ﹤0.01% 1847
2020
Q2
$364K Buy
+7,147
New +$307K ﹤0.01% 3096

Other funds holding ARKG

Wolverine Trading's ARKG Position: Q3 2025 in Review

Wolverine Trading increased its ARK Genomic Revolution ETF (ARKG) stake by 11% in Q3 2025, buying an estimated $102K and bringing the position to 42,447 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Wolverine Trading first reported a position in ARKG in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.9M in Q1 2024. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Wolverine Trading held 42,447 shares of ARK Genomic Revolution ETF worth $1.16M as of Q3 2025.
  • Wolverine Trading bought 4,036 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $102K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2745 holding.
  • Wolverine Trading first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 19 quarters since.
  • Wolverine Trading's ARK Genomic Revolution ETF position peaked at $2.9M in Q1 2024.
  • 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.